LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 49 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,190 | +42.9% | 236,757 | +13.2% | 0.00% | – |
| Q2 2023 | $654,489 | +185.9% | 209,102 | +313.8% | 0.00% | – |
| Q1 2023 | $228,896 | +10.3% | 50,529 | +0.5% | 0.00% | – |
| Q4 2022 | $207,574 | +205.3% | 50,260 | +135.6% | 0.00% | – |
| Q3 2022 | $68,000 | +61.9% | 21,330 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -51.2% | 21,330 | 0.0% | 0.00% | – |
| Q1 2022 | $86,000 | -62.6% | 21,330 | 0.0% | 0.00% | – |
| Q4 2021 | $230,000 | -15.1% | 21,330 | -9.2% | 0.00% | – |
| Q3 2021 | $271,000 | +13.4% | 23,498 | -3.5% | 0.00% | – |
| Q2 2021 | $239,000 | -32.9% | 24,358 | 0.0% | 0.00% | – |
| Q1 2021 | $356,000 | -32.2% | 24,358 | -0.7% | 0.00% | – |
| Q4 2020 | $525,000 | +85.5% | 24,537 | +31.5% | 0.00% | – |
| Q3 2020 | $283,000 | – | 18,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |